4-Bromo-1-ethylpyridin-2(1H)-one, 96%, 1g

Methyl 2-(3,5-difluorophenyl)acetate, 99.0%, 5g

1-BOC-3-ALLYLAZETIDINE, 95.0%, 250mg

3-(3,4-dimethylphenyl)-4'-fluoropropiophenone, 97.0%, 1g

2-Chloro-1-iodo-3-methoxybenzene, 5g

Tert-butyl (1-(pyrimidin-2-yl)piperidin-4-yl)carbamate, 98%, 1g

3-Chlorphenol , ≥98 %, zur Synthese, 1 kg, Glasverpackung

3,5-Dichlorophenol, 98.0%, 10g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 25 m, Ø-Innen 0,25 mm, Filmd. 0,25 µm, 1 Stück

1-Fluoro-3-(2-nitrovinyl)benzene, 95.0%, 250mg

4-Hydroxy-[1,1'-biphenyl]-3-carboxylic acid, 95.0%, 250mg

3,4-Dibromo-7-azaindole, 95.0%, 5g

(4-Phenyl-piperidin-1-yl)-acetic acid, 95.0%, 1g